Dyne Therapeutics, Inc. (DYN) vs Arcus Biosciences, Inc. (RCUS)
Dyne Therapeutics, Inc. and Arcus Biosciences, Inc. are both Biotechnology companies. Dyne Therapeutics, Inc. and Arcus Biosciences, Inc. are of similar size ($3.2B and $3.1B). Dyne Therapeutics, Inc. has the higher net margin (0.00% vs −393.2%) and the lower return on invested capital (−1,956.3% vs 0.00%). Across the 14 metrics below, Dyne Therapeutics, Inc. leads on 8 and Arcus Biosciences, Inc. on 6.
Valuation
Profitability
| Metric | DYN | RCUS | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (415.38%) | 0.00% |
| Net margin | 0.00% | (393.16%) | 0.00% |
| Free cash flow margin | 0.00% | (405.13%) | 0.00% |
| Return on equity | (81.57%) | (90.82%) | (57.72%) |
| Return on assets | (60.29%) | (46.02%) | (49.22%) |
| Return on invested capital | (1,956.27%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack